Prostanoids for Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Prostanoids for Pulmonary Arterial Hypertension

Published:2003-04 Issue:2 Volume:2 Page:123-137
ISSN:1175-6365
Container-title:American Journal of Respiratory Medicine
language:en
Short-container-title:Am J Respir Med

Author:

Galiè Nazzareno,Manes Alessandra,Branzi Angelo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF03256644.pdf

Reference118 articles.

1. Nomenclature Committee. Nomenclature and Classification of Pulmonary Hypertension. In: Rich S. Primary pulmonary hypertension: executive summary from the World Symposium — Primary Pulmonary Hypertension; 1998: 25–27. 1998, World Health Organization. http://www.who.int/ncd/cvd/pph.html

2. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336: 111–7

3. Galie N, Manes A, Uguccioni L, et al. Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest 1998; 114: 184S–94S

4. MacGregor AJ, Canavan R, Knight C, et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 2001; 40: 453–9

5. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults: second of two parts [published erratum appears in N Engl J Med 2000 Mar 30; 342 (13): 988]. N Engl J Med 2000; 342: 334–42

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial Function in Pulmonary Arterial Hypertension: From Bench to Bedside;Journal of Clinical Medicine;2024-04-22

2. Pulmonary arterial hypertension;La Presse Médicale;2023-09

3. Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease;Pharmaceuticals;2023-03-09

4. Hipertensión pulmonar;Medicine - Programa de Formación Médica Continuada Acreditado;2022-11

5. Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes;Pharmaceuticals;2022-10-10